Correlation Between Sigilon Therapeutics and Landos Biopharma
Can any of the company-specific risk be diversified away by investing in both Sigilon Therapeutics and Landos Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sigilon Therapeutics and Landos Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sigilon Therapeutics and Landos Biopharma, you can compare the effects of market volatilities on Sigilon Therapeutics and Landos Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sigilon Therapeutics with a short position of Landos Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sigilon Therapeutics and Landos Biopharma.
Diversification Opportunities for Sigilon Therapeutics and Landos Biopharma
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sigilon and Landos is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Sigilon Therapeutics and Landos Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Landos Biopharma and Sigilon Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sigilon Therapeutics are associated (or correlated) with Landos Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Landos Biopharma has no effect on the direction of Sigilon Therapeutics i.e., Sigilon Therapeutics and Landos Biopharma go up and down completely randomly.
Pair Corralation between Sigilon Therapeutics and Landos Biopharma
If you would invest 402.00 in Landos Biopharma on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Landos Biopharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sigilon Therapeutics vs. Landos Biopharma
Performance |
| Timeline |
| Sigilon Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Landos Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Sigilon Therapeutics and Landos Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sigilon Therapeutics and Landos Biopharma
The main advantage of trading using opposite Sigilon Therapeutics and Landos Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sigilon Therapeutics position performs unexpectedly, Landos Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Landos Biopharma will offset losses from the drop in Landos Biopharma's long position.| Sigilon Therapeutics vs. Reviva Pharmaceuticals Holdings | Sigilon Therapeutics vs. ZyVersa Therapeutics | Sigilon Therapeutics vs. Unicycive Therapeutics | Sigilon Therapeutics vs. Apollomics Class A |
| Landos Biopharma vs. Apollomics Class A | Landos Biopharma vs. Cardio Diagnostics Holdings | Landos Biopharma vs. Transcode Therapeutics | Landos Biopharma vs. Xenetic Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |